PT  - JOURNAL ARTICLE
AU  - Bugeme, Patrick Musole
AU  - Xu, Hanmeng
AU  - Hutchins, Chloe
AU  - Hulse, Juan Dent
AU  - Saidi, Jaime Mufitini
AU  - Rumedeka, Baron Bashige
AU  - Itongwa, Moïse
AU  - Mashauri, Joël Faraja Zigashane
AU  - Lulela, Faraja Masembe
AU  - Bengehya, Justin
AU  - Kulondwa, Jean-Claude
AU  - Debes, Amanda K
AU  - Ciglenecki, Iza
AU  - Tshiwedi, Esperance
AU  - Kitoga, Faida
AU  - Bodisa-Matamu, Tavia
AU  - Nadège, Taty
AU  - Kavunga-Membo, Hugo
AU  - Lunguya, Octavie
AU  - Welo, Placide Okitayemba
AU  - Knee, Jackie
AU  - Mukadi-Bamuleka, Daniel
AU  - Azman, Andrew S.
AU  - Malembaka, Espoir Bwenge
TI  - Cholera deaths during outbreaks in Uvira, eastern Democratic Republic of the Congo, 10-35 months after mass vaccination
AID  - 10.1101/2023.05.26.23290528
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.05.26.23290528
4099  - http://medrxiv.org/content/early/2023/10/23/2023.05.26.23290528.short
4100  - http://medrxiv.org/content/early/2023/10/23/2023.05.26.23290528.full
AB  - Our understanding of the burden and drivers of cholera mortality is hampered by limited surveillance and confirmation capacity. Leveraging enhanced clinical and laboratory surveillance in the cholera-endemic community of Uvira, eastern Democratic Republic of Congo, we describe cholera deaths across three epidemics between September 2021-September 2023, following mass vaccination.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Wellcome Trust and Gavi (GAVI-RFP-2019-062).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approvals were obtained from Institutional Review Boards of the Johns Hopkins Bloomberg School of Public Health (IRB00015785), The London School of Hygiene and Tropical Medicine (25365) and the Ecole de Sante Publique at the University of Kinshasa (ESP/CE/65/2021). I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present work are contained in the manuscript.